The Food and Drug Administration has announced some major changes to the review process for drug developers in the United States. It could cut down the time from 10 to 12 months for a review to just ...
The Food and Drug Administration announced the launch of a new program to fast-track agency approvals for drug manufacturers working on products that could cure chronic disease, prepare for a pandemic ...
The Food and Drug Administration (FDA) updated its guidance on Tuesday to allow more wearables to fall into a general ...
Hosted on MSN
FDA, OpenAI discussing use of AI for drug evaluation
The US Food and Drug Administration (FDA) has been meeting with OpenAI to explore how AI could help make the drug approval process faster and more efficient. This effort is part of a broader ...
Underinvestment in technology to adequately document data may contribute to gaps in the Food and Drug Administration’s drug review process. The FDA has consistently treated IT as a deferrable spending ...
The FDA says it is hiring more than 1,000 new employees and rolling out a pilot communication program in an effort to speed up the review of new drugs. “FDA announced over 40 job announcements for ...
The U.S. FDA has revealed plans to launch a national priority voucher program aimed at reducing the drug review time period for selected manufacturers. The time to review a drug under the program will ...
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
The US Food and Drug Administration (FDA) is launching a “stronger, more systematic” review process for chemicals in food. The US government agency said in a statement, citing US Department of Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback